SUMMARY Two immunofluorescence procedures to evaluate antinuclear antibodies were compared in a series of 221 patients with chronic liver disorders of various aetiologies. The use of HEp-2 cells allowed us to discriminate with more confidence between the homogeneous and speckled patterns, to show the presence of associated patterns in the same serum, and, above all, to identify two specificities, unrecognisable on tissue sections. The anticentromere antibody was found in 10% of cases of primary biliary cirrhosis and occasionally in other conditions; the antibody staining multiple nuclear dots was strictly confined to primary biliary cirrhosis (17%). With the exception of autoimmune chronic active hepatitis the prevalence of antinuclear antibodies increased in all groups, particularly in primary biliary cirrhosis. Homogeneous antinuclear antibody was associated by both immunofluorescence procedures with autoimmune chronic active hepatitis. The multiple nuclear dot antinuclear antibody turned out to be an additional marker of primary biliary cirrhosis, helpful for the positive diagnosis of primary biliary cirrhosis in a proportion of cases negative for antimitochondrial antibody. Absorption experiments showed that multiple nuclear dot and antimitochondrial antibody are antigenically distinct. Moreover, multiple nuclear dot antinuclear antibody was associated with the finding of a dry Schirmer's test.
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Antinuclear antibodies are found in the serum of patients with chronic liver disorders. The method routinely used to detect them is the indirect immunofluorescence procedure with frozen tissue sections as substrate, which also allows recognition of different patterns of positivity. The diagnostic relevance of the antinuclear antibodies detected by this method is confined to the identification of the autoimmune subgroup of chronic active hepatitis, where antinuclear antibodies, mainly giving a homogeneous staining pattern,' are to be found at a high titre (1/20-1/80). The titre of anticentromere antibody and multiple nuclear dot staining was unaffected by preabsorption of the serum with sonicated mitochondrial fraction, whereas the cytoplasmic staining seen with most primary biliary cirrhosis sera samples was always affected.
Tear secretion was reduced in eight of the 22 primary biliary cirrhosis patients tested (36%). Multiple nuclear dot antinuclear antibody occurred in four (50%) of these eight patients, but in only one (7%) of the 14 patients without sicca syndrome (p < 0-01, Fischer's exact test).
Discussion
Immunological tests have an established place in the classification and differential diagnosis of chronic liver disease. Besides M2-antimitochondrial antibody, found in primary biliary cirrhosis, and liver kidney microsomal antibody, which identifies a sub- Cassani, Bianchi, Lenzi, Volta, Pisi scleroderma were not reviewed in our study. As in Bernstein's study3 multiple nuclear dot antinuclear antibody on HEp-2 cells seems to be highly specific for primary biliary cirrhosis and can be considered a serological marker of this disease, albeit a much less sensitive one than antimitochondrial antibody. The multiple nuclear dot pattern was given by two of the 14 antimitochondrial antibody negative primary biliary cirrhosis serum samples included in this study. Since primary biliary cirrhosis can be difficult to diagnose in the absence of antimitochondrial antibody, the finding of multiple nuclear dot antinuclear antibody may be helpful in such cases.8 It remains to be seen whether patients with multiple nuclear dot antinuclear antibody become antimitochondrial antibody positive later. Our absorption studies show that multiple nuclear dot antinuclear antibody and antimitochondrial antibody are antigenically distinct. In terms of clinical relevance this study confirms that multiple nuclear dot antinuclear antibody is associated with the sicca syndrome in primary biliary cirrhosis. We thank Dr Robert M Bernstein (Rheumatology Unit, Hammersmith Hospital, London) for the helpful suggestions in revising the manuscript. This study was supported in part by CNR grant no 83.02112.
